Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Aldeyra Therapeu (NQ: ALDX)
5.135 USD  -0.185 (-3.48%)
Official Closing Price  /  Updated: 4:00 PM EST, Dec 13, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 235,400
Open 5.440
Bid (Size) 4.750 (25)
Ask (Size) 5.420 (4)
Prev. Close 5.320
Today's Range 5.110 - 5.440
52wk Range 4.310 - 12.79
Shares Outstanding 20,109,394
Dividend Yield N/A
Performance
YTD
-39.66%
-39.66%
1 Month
-14.84%
-14.84%
3 Month
-12.22%
-12.22%
6 Month
-22.90%
-22.90%
1 Year
-41.78%
-41.78%
Top News
More News
Aldeyra Therapeutics Announces Positive Top-Line Results from Part 1 of Adaptive Phase 3 RENEW Trial in Dry Eye Disease
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated... Read More
from Business Wire News Releases
Aldeyra Therapeutics to Host Conference Call and Webcast to Announce Top-Line Results from Part 1 of Adaptive Phase 3 RENEW Trial in Dry Eye Disease
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Tuesday, December 3, 2019, to provide top-line results from Part 1 of the adaptive Phase 3... Read More
from Business Wire News Releases
More News
Read More
Aldeyra Therapeutics to Present at Upcoming Healthcare Investor Conferences
from Business Wire News Releases
How The Pieces Add Up: VXF Targets $136
category ETFs
from ETF Channel
Aldeyra Therapeutics Reports Third-Quarter 2019 Financial Results and Provides Updates on Anticipated Clinical Milestones
from Business Wire News Releases
Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Third-Quarter 2019 Financial Results and Corporate Update
from Business Wire News Releases
Mid-Morning Market Update: Markets Open Lower; Cleveland-Cliffs To Acquire AK Steel For $3.36/Share
category CLF , News , ASLN , and 16 more.
from Benzinga
Aldeyra Therapeutics Releases Expanded Results from Allergen Chamber Trial and Announces Plans to Initiate the Phase 3 INVIGORATE Trial in Patients with Allergic Conjunctivitis
from Business Wire News Releases
Aldeyra Therapeutics to Host Conference Call and Webcast to Release Expanded Results from Allergen Chamber Trial and Announce Design of Phase 3 INVIGORATE Trial in Patients with Allergic Conjunctiviti
from Business Wire News Releases
Analysts See 21% Upside For VTWG
category ETFs
from ETF Channel
Mid-Afternoon Market Update: US Markets Down, Dow Loses More Than 200 Points
category Earnings , CNSL , CANF , and 16 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.